Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection

被引：1

作者：

Schenone, Eva ^{[1
]}

Di Biagio, Antonio ^{[1
]}

Parisini, Andrea ^{[1
]}

Bruzzone, Bianca ^{[2
]}

Sticchi, Laura ^{[2
]}

Calzi, Anna ^{[1
]}

Nicco, Elena ^{[1
]}

Secondo, Giovanni ^{[1
]}

Viscoli, Claudio ^{[1
]}

机构：

[1] Univ Genoa, San Martino Hosp, Clin Malattie Infett, I-16132 Genoa, Italy

[2] Univ Genoa, San Martino Hosp, Ist Igiene, I-16132 Genoa, Italy

来源：

JOURNAL OF CHEMOTHERAPY | 2012年 / 24卷 / 01期

关键词：

Protease inhibitor monotherapy; Human immunodeficiency virus; Adolescents; Perinatal transmission; Mother-to-child transmission; lopinavir/ritonavir; LOPINAVIR-RITONAVIR MONOTHERAPY; THERAPY;

D O I：

10.1179/1120009X12Z.00000000011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, the use of boosted protease inhibitors monotherapy has become increasingly important, especially considering the advantages in terms of costs, tolerability, and simplification. Despite that, knowledge about the efficacy and safety of this approach in HIV-1-infected adolescents who have acquired HIV-1 infection through perinatal transmission is still limited. We report here our experience with two adolescents who have been successfully treated with lopinavir/ritonavir monotherapy.

引用

页码：56 / 58

页数：3

共 50 条

[1] Simplification to lopinavir/ritonavir monotherapy in HIV-infected children
Mur-Sierra, A.
Lopez-Segura, N.
Lopez-Vilchez, M. A.
[J]. ANALES DE PEDIATRIA, 2011, 75 (01): : 51 - 54
[2] Controversial approaches in HIV infection: Is there a role for lopinavir/ritonavir monotherapy?
Chan-Tack, Kirk M.
Edozien, Anthony
[J]. INFECTIONS IN MEDICINE, 2006, 23 (08) : 342 - +
[3] Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial
Meynard, Jean-Luc
Bouteloup, Vincent
Landman, Roland
Bonnard, Philippe
Baillat, Vincent
Cabie, Andre
Kolta, Sami
Izopet, Jacques
Taburet, Anne-Marie
Mercie, Patrick
Chene, Genevieve
Girard, Pierre-Marie
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (11) : 2436 - 2444
[4] Lopinavir/Ritonavir A Review of its Use in the Management of HIV-1 Infection
Croxtall, Jamie D.
Perry, Caroline M.
[J]. DRUGS, 2010, 70 (14) : 1885 - 1915
[5] HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavir
Sutherland, K. A.
Ghosn, J.
Gregson, J.
Mbisa, J. L.
Chaix, M. L.
Codar, I. Cohen
Delfraissy, J. F.
Delaugerre, C.
Gupta, R. K.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) : 243 - 248
[6] EARLY DIAGNOSIS OF VERTICALLY ACQUIRED HIV-1 INFECTION
TUDORWILLIAMS, G
[J]. AIDS, 1991, 5 (01) : 103 - 105
[7] Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice
Molto, Jose
Santos, Jose Ramon
Negredo, Eugenia
Miranda, Cristina
Videla, Sebastia
Clotet, Bonaventura
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 436 - 439
[8] HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir
Bunupuradah, Torsak
Bowonwattanuwong, Chureeratana
Jirajariyavej, Supunnee
Munsakul, Warangkana
Klinbuayaem, Virat
Sophonphan, Jiratchaya
Mahanontharit, Apicha
Hirschel, Bernard
Ruxrungtham, Kiat
Ananworanich, Jintanat
[J]. ANTIVIRAL THERAPY, 2014, 19 (06) : 579 - 586
[9] Cerebrospinal fluid HIV-1 virological escape with lymphocytic meningitis under lopinavir/ritonavir monotherapy
de Truchis, Pierre
Mathez, Dominique
Abe, Emuri
Dinh, Aurelien
LeDu, Damien
Greder-Belan, Alix
Alvarez, Jean-Claude
[J]. AIDS, 2010, 24 (08) : 1235 - 1236
[10] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
Barragan, Patricia
Podzamczer, Daniel
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375

← 1 2 3 4 5 →